Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N ATKINSON

Showing results (191-200 of 262) with videos related to

Pageof 27
Sort By:
The New England Journal of Medicine|December 11, 1986
13-cis-retinoic acid in the treatment of oral leukoplakiaW K Hong, J Endicott, L M Itri, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
European Journal of Medicinal Chemistry|March 19, 2023
Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activityBenjamin N Atkinson, Nicky J Willis, Yuguang Zhao, et al.
Msystems|January 25, 2022
Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in MiceValery V Lozada-Fernández, Orlando deLeon, Stephanie L Kellogg, et al.
Cancer|January 15, 1993
Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experienceD M Gershenson, M F Mitchell, N Atkinson, et al.
American Journal of Clinical Oncology|June 1, 1989
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinomaR S Freedman, J M Bowen, E N Atkinson, et al.
Cancer Research|November 1, 1993
Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptorD G Kieback, S K McCamant, M F Press, et al.
Gynecologic Oncology|May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragmentDonna Badgwell, Zhen Lu, Laurence Cole, et al.
Journal of Medicinal Chemistry|March 30, 2021
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt SignalingElliott D Bayle, Fredrik Svensson, Benjamin N Atkinson, et al.
Cancer Research|July 10, 2007
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagyShoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng, et al.
Pageof 27

Showing results (191-200 of 262) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|December 11, 1986
13-cis-retinoic acid in the treatment of oral leukoplakiaW K Hong, J Endicott, L M Itri, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
European Journal of Medicinal Chemistry|March 19, 2023
Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activityBenjamin N Atkinson, Nicky J Willis, Yuguang Zhao, et al.
Msystems|January 25, 2022
Nicotinamide Riboside-Conditioned Microbiota Deflects High-Fat Diet-Induced Weight Gain in MiceValery V Lozada-Fernández, Orlando deLeon, Stephanie L Kellogg, et al.
Cancer|January 15, 1993
Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experienceD M Gershenson, M F Mitchell, N Atkinson, et al.
American Journal of Clinical Oncology|June 1, 1989
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinomaR S Freedman, J M Bowen, E N Atkinson, et al.
Cancer Research|November 1, 1993
Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptorD G Kieback, S K McCamant, M F Press, et al.
Gynecologic Oncology|May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragmentDonna Badgwell, Zhen Lu, Laurence Cole, et al.
Journal of Medicinal Chemistry|March 30, 2021
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt SignalingElliott D Bayle, Fredrik Svensson, Benjamin N Atkinson, et al.
Cancer Research|July 10, 2007
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagyShoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng, et al.
Pageof 27